Menu

Eli Lilly told HRSA Monday that certain covered entities have five days to comply with its in-house claims data requirements or will lose access to 340B drug pricing.

News Alert

Lilly Demands Certain CEs Submit Claims Data in Five Days or Lose 340B Pricing, Will Extend to Others Later

June 2, 2026 Luke Zarzecki, National Correspondent 340B Report Views

An Indiana-based pharmaceutical giant told federal regulators Monday that an “initial set of covered entities” have five days to comply [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Luke Zarzecki

Federal Judge Hearing PhRMA’s Maine 340B Law Challenge Was Partner at Firm that Lobbied for PhRMA Last Year Against Bill

Expert Tip from SunRx